All enrolled clients who gained at least 1 dose of zosuquidar or placebo all through induction had been monitored for your occurrence of adverse situations (439 clients, 219 on zosuquidar and 210 on placebo). The most typical adverse situations ended up connected with the period of extended and substantial myelosuppression https://catmanw072wis8.blogsuperapp.com/profile